Authors
Latest:
Impact on the FutureThe use of RBM may be the only way forward as long as the development of medicines relies on clinical testing.
Latest:
Blood Pressure Evaluation During Early Phase TrialsA systematic approach for early identification of BP effects during development of new drugs.
Latest:
Getting to Clinical Trial DiversityDiffering levels of trust in clinical trials information channels across diverse populations is examined in this research.
Latest:
eSource Records in Clinical Research: Keeping it SimpleHow to satisfy regulatory concerns about EDC data integrity and site controls over its source records.
Latest:
The Case for Universal GCP EducationThe primary objectives of GCP are to protect the safety, rights, and welfare of subjects, and to ensure the credibility of trial data and resulting reports.
Latest:
Academic Medical Centers Can Tackle CTMS SuccessfullyThe excessive cost of clinical trials mixed with the inefficiency of clinical trial management is a widespread problem among research institutions.
Latest:
Shifting the Large Simple Trials ParadigmConducting Large Simple Trials to answer questions about "real-world" medical interventions is not a recent concept.
Latest:
An Ideal SOP SystemA "can’t live with them, can’t live without them" attitude is revealed in survey of standard operating procedures in the management and conduct of clinical trials.
Latest:
An Ideal SOP SystemA "can’t live with them, can’t live without them" attitude is revealed in survey of standard operating procedures in the management and conduct of clinical trials.
Latest:
Impact on the FutureThe use of RBM may be the only way forward as long as the development of medicines relies on clinical testing.
Latest:
Practical Thoughts on Common Standards: CDASH and E2B for Safety ReportingClinical research is complicated, and it?s not just the science. Take CDASH, CDISC and E2B for example. Aren?t acronyms awesome?
Latest:
The Importance of Detailed Patient Consent TrackingPatient consent is important to stay on top of for many reasons.
Latest:
CTMS: What You Should KnowThe dilemma facing clinical operations executives when selecting a CTMS solution to manage clinical trials is to go with an existing approach/solution or explore alternative options.
Latest:
SOPs in Clinical ResearchSurvey appraises the use of SOPs in clinical research from the sponsors' point of view.
Latest:
Re-Branding "Risk-Based Monitoring" - A Call for "Targeted Site Quality Management"With all of the buzz and excitement around risk-based monitoring, one might expect that the broad adoption of this emerging clinical research paradigm is well under way.
Latest:
Three-Pronged Approach to Optimizing Trial MonitoringStudy results using a quality-by-design method, risk-based monitoring, and real-time direct data entry.
Latest:
Enhancing Trial Enrollment Through 'Goal Programming'How iterative analysis of subject recruitment data can optimize outcomes during ongoing enrollment.
Latest:
Technology’s Role in Clinical TrialsHow the use of eSource, eTMF, and other cloud-based solutions are changing clinical trials
Latest:
Decline of Trials in CEE: Fluctuation or Trend?Examining why newly registered trials have fallen in Central and Eastern Europe, relative to other regions.
Latest:
Recruiting Strategies for Clinical TrialsSix years ago, our department of a large academic research center was having difficulty enrolling enough subjects in osteoporosis studies. We wanted to expand into a variety of trials and increase the number of participants. Despite our experience and expertise, our enrollments were down. We wondered if the pool of eligible participants was shrinking, if our competition was doing a better job than we were, or if we needed to modify our project management style.
Latest:
Perspectives and Guidance for Effective eCOA in Global DCTsGuidance on the unique challenges presented by electronic outcomes.
Latest:
Three Reasons to Integrate a CTMS and EMRIntegrating a CTMS and an EMR can provide many benefits for supporting the health care needs of patients.
Latest:
Blood Pressure Evaluation During Early Phase TrialsA systematic approach for early identification of BP effects during development of new drugs.
Latest:
RBM in Late PhaseThe reality of risk-based monitoring: history and successful implementation for late phase research.
Latest:
Developing a Successful Peer-to-Peer Mentoring ProgramClinical research organizations should look to peer-to-peer mentoring for professional development.
Latest:
Decline of Clinical Trials in Central and Eastern Europe: Fluctuation or Trend?In some countries, the participation in clinical trial, is still the only possibility to be treated.
